Author

Manaka Sato

Observed name: Sato, Manaka

Institutions: Eli Lilly (Japan), International University of Health and Welfare

Observed institutions: Eli Lilly (Japan), International University of Health and Welfare

ORCID: 0000-0001-7000-4769

Observed ORCID: 0000-0001-7000-4769

OpenAlex ID: A5047594159

Effects of Icodextrin on Glycemic and Lipid Profiles in Diabetic Patients Undergoing Peritoneal Dialysis

2007 · Tetsuya Babazono, Hidetomo Nakamoto, et al. · American Journal of Nephrology · 67

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)

2022 · Shinichiro Shirabe, Katsuya Yamazaki, et al. · Journal of Diabetes Investigation · 23

Efficacy and safety analyses across 4 subgroups combining low and high age and body mass index groups in Japanese phase 3 studies of dulaglutide 0.75 mg after 26 weeks of treatment

2017 · Kumiko Hamano, Hiroshi Nishiyama, et al. · Endocrine Journal · 16

Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study

2024 · Kazuo Hara, Tetsuaki Hirase, et al. · Diabetes Therapy · 12

Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study

2023 · Yasushi Ishigaki, Tetsuaki Hirase, et al. · Diabetes Therapy · 10

Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey

2024 · Hitoshi Ishii, Yasutaka Maeda, et al. · Diabetes Therapy · 5

Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis.

2005 · Hidetomo Nakamoto, Tetsuya Babazono, et al. · PubMed · 4

The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan

2024 · Toshihiko Aranishi, Ataru Igarashi, et al. · Diabetes Therapy · 2

Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study

2026 · Arihiro Kiyosue, Manaka Sato, et al. · Advances in Therapy

Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report

2026 · Manaka Sato, Riku Takemura, et al. · Journal of Clinical Medicine Research

Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan

2025 · Toshihiko Aranishi, Ataru Igarashi, et al. · Diabetes Therapy

高齢日本人2型糖尿病患者における Glp-1・gip/glp-1 受容体作動薬および慎重投与を要する血糖降下薬の処方実態

· Sato, Manaka · Institutional Repositories DataBase (IRDB)

Works count: 14

Citation count: 139

H-index: 5

I10-index: 5